journal article·2015-07-24Open access

Nanochain and vesicles formed by inclusion complexation of 4,4′-diaminobenzanilide with cyclodextrins

N. Rajendiran, R.K. Sankaranarayanan, J. Saravanan

Publisher page

Abstract

The nanochain-like agglomerates and spherical nanovesicles were formed from supramolecular self-assembly of 4,4′-diaminonenzanilide (DABA) with α- and β-cyclodextrins. The DABA with α-CD and β-CD inclusion complex nanomaterials were prepared and characterised by transmission electron microscopy, scanning electron microscopy, FTIR, differential scanning calorimetry, 1H NMR and powder X-ray diffraction. 1H NMR analysis indicated that the benzamido ring of DABA was encapsulated into the cyclodextrin (CD) cavity. Absorption and fluorescence spectral studies suggested that DABA forms different types of nanomaterials in α-CD and β-CD solutions. Higher occupied molecular orbital, lower unoccupied molecular orbital, and thermodynamic parameter values confirmed DABA dye entrapped in the CD cavities.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems · Supramolecular Chemistry and Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (44)

Show source-provided references
1. 10.1021/cr970022c10.1021/cr970022c ↗
2. 10.1016/j.carbpol.2009.01.03310.1016/j.carbpol.2009.01.033 ↗
3. 10.1021/cr960371r10.1021/cr960371r ↗
4. 10.1021/la804316u10.1021/la804316u ↗
5. 10.1016/j.polymer.2009.04.03410.1016/j.polymer.2009.04.034 ↗
6. 10.1007/s10965-008-9240-010.1007/s10965-008-9240-0 ↗
7. 10.1021/cr970027+10.1021/cr970027+ ↗
8. 10.1021/jo801995f10.1021/jo801995f ↗
9. 10.1126/science.107497210.1126/science.1074972 ↗
10. 10.1039/b803782p10.1039/b803782p ↗
11. 10.1021/ja982865710.1021/ja9828657 ↗
12. 10.1002/1521-3757(20001201)112:23<4494::AID-ANGE4494>3.0.CO;2-K10.1002/1521-3757(20001201)112:23<4494::AID-ANGE4494>3.0.CO;2-K ↗
13. 10.1039/b009908m10.1039/b009908m ↗
14. 10.1007/s10847-010-9785-510.1007/s10847-010-9785-5 ↗
15. 10.1002/chem.20080142910.1002/chem.200801429 ↗
16. 10.1002/chem.20070072910.1002/chem.200700729 ↗
17. 10.1016/S0169-409X(98)00053-210.1016/S0169-409X(98)00053-2 ↗
18. Silvera A · Pharm Res · 15 · 1051
19. 10.1007/s10847-006-9085-210.1007/s10847-006-9085-2 ↗
20. 10.1016/j.jconrel.2005.03.00610.1016/j.jconrel.2005.03.006 ↗
21. 10.1021/cr950202r10.1021/cr950202r ↗
22. 10.1016/S1010-6030(96)04380-810.1016/S1010-6030(96)04380-8 ↗
23. 10.1016/S1010-6030(99)00030-110.1016/S1010-6030(99)00030-1 ↗
24. Kim TH · J Phys Chem · 1996 · 1601 · 5670
25. 10.1016/S0009-2614(02)00903-X10.1016/S0009-2614(02)00903-X ↗
26. 10.1039/ft996920002910.1039/ft9969200029 ↗
27. 10.1021/ja01176a03010.1021/ja01176a030 ↗
28. 10.1016/j.saa.2009.06.04910.1016/j.saa.2009.06.049 ↗
29. 10.1021/jp302162g10.1021/jp302162g ↗
30. 10.1007/s10953-010-9559-010.1007/s10953-010-9559-0 ↗
31. 10.1016/j.molstruc.2012.06.02510.1016/j.molstruc.2012.06.025 ↗
32. 10.1007/s10847-012-0248-z10.1007/s10847-012-0248-z ↗
33. Jude Jenita M · Indian J Chem Section A · 2012 · 51 · 1686
34. 10.1016/j.saa.2007.01.00410.1016/j.saa.2007.01.004 ↗
35. 10.1016/j.saa.2009.09.01810.1016/j.saa.2009.09.018 ↗
36. 10.1016/j.molliq.2009.01.00510.1016/j.molliq.2009.01.005 ↗
37. 10.1021/ar50116a00410.1021/ar50116a004 ↗
38. 10.1039/b210851h10.1039/b210851h ↗
39. 10.1021/jp048314m10.1021/jp048314m ↗
40. 10.1021/jp036313910.1021/jp0363139 ↗
41. 10.1021/ar040113d10.1021/ar040113d ↗
42. 10.1016/j.carres.2010.11.00310.1016/j.carres.2010.11.003 ↗
43. 10.1007/s10847-006-9219-610.1007/s10847-006-9219-6 ↗
44. 10.1023/A:101887252421710.1023/A:1018872524217 ↗